In a paper published in Forensic Medicine & Toxicology Vol (13), No(4) oct-December 2019 , Mr. Mohammed Ahmad Sulatan, Pediatric assistant Lecturer and, together with colleagues from Three Iraqi Universities , reports the findings of a descriptive study carried out between 2018 and 2019 on patients with of Hemophilia that report QoL scores. “We saw that, each year, the scientific literature was occupied with dozens of new analyses showing the value of QoL scores, but these were single analyses and many of the trials had limited methods,” says Mr. Sultan. In demanding better standards for future research in the field of prognostic prediction—being able to tell patients what survival duration they can expect—the researchers hope that patients will be able to better adapt their lives to the impact of the Hemophilic diagnosis on their survival. “Although this will not alter practice, it will encourage clinicians to take more interest in patients’ QoL scores and to understand their importance. They are vital in making services and care specific for each patient.